Go Pro
→ A new income category is drawing serious money - here's why (From Investors Alley) (Ad)tc pixel Free RVMDW Stock Alerts

Revolution Medicines (RVMDW) Competitors

Revolution Medicines logo
$11.98 +0.36 (+3.10%)
Closing price 09/3/2026 03:59 PM Eastern
Extended Trading
$11.76 -0.22 (-1.83%)
As of 04:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

RVMDW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Revolution Medicines stock or one of its competitors? Revolution Medicines's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Revolution Medicines compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Revolution Medicines (NASDAQ:RVMDW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

In the previous week, Revolution Medicines had 1 more articles in the media than Alvotech. MarketBeat recorded 2 mentions for Revolution Medicines and 1 mentions for Alvotech. Alvotech's average media sentiment score of 0.92 beat Revolution Medicines' score of 0.16 indicating that Alvotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alvotech
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Revolution Medicines
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Revolution Medicines N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
Revolution MedicinesN/AN/AN/AN/AN/A

Summary

Alvotech beats Revolution Medicines on 2 of the 3 factors compared between the two stocks.

How does Revolution Medicines compare to Apollomics?

Revolution Medicines (NASDAQ:RVMDW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

In the previous week, Revolution Medicines had 2 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for Revolution Medicines and 0 mentions for Apollomics. Revolution Medicines' average media sentiment score of 0.16 beat Apollomics' score of 0.00 indicating that Revolution Medicines is being referred to more favorably in the media.

Company Overall Sentiment
Revolution Medicines Neutral
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Revolution Medicines beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Revolution Medicines compare to Aravive?

Revolution Medicines (NASDAQ:RVMDW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Revolution Medicines had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for Revolution Medicines and 0 mentions for Aravive. Revolution Medicines' average media sentiment score of 0.16 beat Aravive's score of 0.00 indicating that Revolution Medicines is being referred to more favorably in the media.

Company Overall Sentiment
Revolution Medicines Neutral
Aravive Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
Aravive N/A N/A N/A

Summary

Revolution Medicines and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does Revolution Medicines compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Revolution Medicines (NASDAQ:RVMDW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
Revolution MedicinesN/AN/AN/AN/AN/A

In the previous week, bioAffinity Technologies and bioAffinity Technologies both had 2 articles in the media. Revolution Medicines' average media sentiment score of 0.16 beat bioAffinity Technologies' score of -0.66 indicating that Revolution Medicines is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
bioAffinity Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Negative
Revolution Medicines
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Revolution Medicines N/A N/A N/A

Summary

bioAffinity Technologies and Revolution Medicines tied by winning 1 of the 2 factors compared between the two stocks.

How does Revolution Medicines compare to BioVie?

Revolution Medicines (NASDAQ:RVMDW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Revolution Medicines had 1 more articles in the media than BioVie. MarketBeat recorded 2 mentions for Revolution Medicines and 1 mentions for BioVie. Revolution Medicines' average media sentiment score of 0.16 beat BioVie's score of 0.00 indicating that Revolution Medicines is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revolution Medicines
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioVie
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

Revolution Medicines beats BioVie on 2 of the 2 factors compared between the two stocks.

Get Revolution Medicines News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVMDW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVMDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVMDW vs. The Competition

Export
MetricRevolution MedicinesBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$4.03B$7.26B$12.73B
Dividend YieldN/A3.60%2.53%8.86%
P/E RatioN/A12.66273.2925.25
Price / SalesN/A1,335.53621.7997.64
Price / CashN/A106.8777.8252.26
Price / BookN/A16.8113.086.14
Net IncomeN/A-$22.72M$3.47B$349.01M
7 Day Performance2.92%0.14%0.52%-0.31%
1 Month Performance19.56%8.27%5.63%0.64%
1 Year Performance6,285.93%52.60%25.31%14.83%

Revolution Medicines Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVMDW
Revolution Medicines
N/A$11.98
+3.1%		N/A+6,555.6%$0.00N/AN/A378
ALVOW
Alvotech
N/A$0.40
-18.4%		N/A-73.0%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.01
flat		N/A+42.3%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.13
+77.1%		N/A+1,001.7%$0.00$5.85MN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:RVMDW) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Earth's biggest energy source: near Grand Canyon
The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...
Behind the Markets | Sponsoredtc pixel